206 results
·
7ms
·
Sources: EU EUDAMED, US FDA
AIE REGION OF INTEREST IMAGE ENHANCEMENT
FDA 510(k)
FDA Class 2
·Radiology
H. INFLUENZA B ANTISERA FOR CIE
FDA 510(k)
FDA Class 2
·Microbiology
EN TYPING CIE KIT FOR DIAGNOSTIC USE
FDA 510(k)
FDA Class 2
·Immunology
ENA SCREENING CIE KIT FOR DIAGNOSTIC USE
FDA 510(k)
FDA Class 2
·Immunology
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·TANDEM(R)-E AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·TANDEM(R)-E AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP (LIST 7A48)
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·TANDEM(R)-E AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP (LIST 7A48)
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AFP-EIA DIAGNOSTIC KIT FOR NTDS
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AFP-EIA LABELING CHANGE
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT AXSYM AFP (LIST 7A48)
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ENZYMUN-TEST{R} AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·AFP CONTROL PACK
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ENCORE AFP